Free Trial

Fate Therapeutics (FATE) SEC Filings & 10K Form

Fate Therapeutics logo
$1.88 -0.12 (-6.00%)
(As of 12/17/2024 ET)

Recent Fate Therapeutics SEC Filings

DateFilerForm TypeView
12/16/2024
8:00 PM
Fate Therapeutics (Issuer)
Green Jeremy (Reporting)
Redmile Group, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2024
1:33 PM
Fate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
6:50 PM
Fate Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G/A
10/25/2024
8:37 PM
Boxer Capital Management, LLC (Filed by)
Fate Therapeutics (Subject)
Form SC 13G/A
10/21/2024
3:11 PM
BlackRock, Inc. (Filed by)
Fate Therapeutics (Subject)
Form SC 13G/A
08/30/2024
3:21 PM
Fate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
3:01 PM
Fate Therapeutics (Issuer)
Xu Yuan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
9:34 AM
Fate Therapeutics (Subject)
Xu Yuan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/31/2024
4:59 PM
Fate Therapeutics (Issuer)
Mozaffarian Neelufar (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/31/2024
5:00 PM
Fate Therapeutics (Issuer)
TAHL CINDY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
5:01 PM
Fate Therapeutics (Issuer)
Mozaffarian Neelufar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
5:05 PM
Fate Therapeutics (Issuer)
Valamehr Bahram (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
3:03 PM
Fate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2024
5:19 PM
Fate Therapeutics (Issuer)
Green Jeremy (Reporting)
Redmile Group, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
5:20 PM
Fate Therapeutics (Issuer)
Lee Michael Stewart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
3:35 PM
Fate Therapeutics (Issuer)
RASTETTER WILLIAM H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
3:30 PM
Fate Therapeutics (Issuer)
Jooss Karin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
4:05 PM
Fate Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/10/2024
3:31 PM
Fate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
4:26 PM
Fate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2024
4:24 PM
Fate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
8:01 AM
Fate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
11:15 PM
Fate Therapeutics (Filer)
Form EFFECT
04/26/2024
3:16 PM
Fate Therapeutics (Filer)
Form ARS
03/25/2024
8:30 PM
Fate Therapeutics (Issuer)
Green Jeremy (Reporting)
Redmile Group, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
4:15 PM
Fate Therapeutics (Subject)
Redmile Group, LLC (Filed by)
Form SC 13D/A
03/20/2024
4:30 PM
Fate Therapeutics (Filer)
Form 424B5
03/04/2024
12:29 PM
Dulac Edward J III (Reporting)
Fate Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2024
5:06 PM
Boxer Capital, LLC (Filed by)
Fate Therapeutics (Subject)
Form SC 13G
02/09/2024
5:19 PM
Capital World Investors (Filed by)
Fate Therapeutics (Subject)
Form SC 13G/A
01/30/2024
3:01 PM
Dulac Edward J III (Reporting)
Fate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2024
12:44 PM
Dulac Edward J III (Reporting)
Fate Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/24/2024
8:46 AM
BlackRock Inc. (Filed by)
Fate Therapeutics (Subject)
Form SC 13G/A
01/22/2024
12:46 PM
Fate Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/10/2024
3:29 PM
Dulac Edward J III (Reporting)
Fate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
3:29 PM
Fate Therapeutics (Issuer)
Wolchko J Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
3:30 PM
Fate Therapeutics (Issuer)
Valamehr Bahram (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
3:30 PM
Fate Therapeutics (Issuer)
TAHL CINDY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
3:35 PM
Fate Therapeutics (Subject)
Valamehr Bahram (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:36 PM
Fate Therapeutics (Subject)
TAHL CINDY (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:36 PM
Dulac Edward J III (Reporting)
Fate Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Forbes rich list released… #1 to be assassinated? (Ad)

Elon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people are slowly starting to wake up to the Deep State’s lies.

To get the full details on the fake “energy crisis” of America, watch this now
01/09/2024
3:39 PM
Fate Therapeutics (Subject)
Wolchko J Scott (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/02/2024
11:17 AM
Dulac Edward J III (Reporting)
Fate Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/28/2023
8:30 PM
Fate Therapeutics (Issuer)
Green Jeremy (Reporting)
Redmile Group, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2023
3:53 PM
Fate Therapeutics (Subject)
Form SC 13D/A
12/28/2023
3:53 PM
Fate Therapeutics (Subject)
Redmile Group, LLC (Filed by)
Form SC 13D/A
12/18/2023
10:40 AM
Dulac Edward J III (Reporting)
Fate Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:FATE) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners